
Speciality chemicals startup Atomgrid has raised $7 million, or about ₹58 crore, in a pre-Series A funding round, as per The Economic Times report. The capital has been raised through a combination of equity and debt, the company said.
The equity portion of the round was led by A99. New investors Sadev Ventures and CDM Capital also participated, along with existing backer Merak Ventures. Debt funding was provided by Trifecta, SIDBI, and RevX.
Atomgrid said the funds will be used to expand exports, set up local teams and offices in overseas markets, and support research and development. The company plans to use part of the capital for the development and launch of new speciality chemical products.
Founded by IIT-BHU alumni Siddharth Gupta, Lakshit Bansal, and Pratik Chowdhury, Atomgrid operates a contract development, manufacturing, and sourcing platform. Its business spans four segments, pharmaceuticals, agriculture, personal care, and flavours and fragrances.
The company claims to operate more than 20 manufacturing sites located in Ankleshwar, Dahej, Sachin, and Bharuch in Gujarat, as well as Hyderabad in Telangana. Atomgrid reports a total production capacity of over 5,000 metric tonnes per annum and operates more than five research and development centres.
According to the company, exports account for over 50% of its revenue. Atomgrid serves more than 150 active customers across over 15 countries. It has stated a target of three times year-on-year revenue growth in FY26.
Atomgrid raised ₹10 crore in a seed funding round in 2024. Prior to the latest raise, the company had secured $1.25 million in May last year.
Read More: Finops Firm Bluecopa Secures $7.5 Million in Funding Led by Analog Partners and Blume Ventures!
The latest funding adds to a series of recent capital raises by Indian speciality chemicals firms as companies look to expand capacity and international reach.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jan 14, 2026, 11:35 AM IST

Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
